Market Tracker

09/01 6:02pm ET

Exelixis Inc (NASDAQ:EXEL)

5.60
Delayed Data
As of Sep 01
 -0.35 / -5.88%
Today’s Change
1.26
Today|||52-Week Range
6.81
+288.89%
Year-to-Date

Today’s Trading

Previous close5.95
Today’s open5.75
Day’s range5.47 - 5.85
Volume10,047,483
Average volume (3 months)6,492,864
Market cap$1.3B
Dividend yield--
Data as of 3:59pm ET, 09/01/2015

Growth & Valuation

Earnings growth (last year)-3.76%
Earnings growth (this year)+40.94%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)-19.87%
P/E ratioNM
Price/Sales11.14
Price/Book--

Competitors

 Today’s
change
Today’s
% change
LXRXLexicon Pharmaceutic...-0.19-1.59%
NKTRNektar Therapeutics-0.30-2.71%
FGENFibroGen Inc-1.66-6.78%
NXTMNxStage Medical Inc-0.77-4.43%
Data as of 3:59pm ET, 09/01/2015

Financials

Next reporting dateOctober 28, 2015
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$25.1M
Annual profit (last year)-$268.5M
Net profit margin-1,069.42%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael M. Morrissey
Chief Financial Officer &
Executive Vice President
Christopher J. Senner
Corporate headquarters
South San Francisco, California

Forecasts